Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07203352 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

Name: Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL — clinical trial record (NCT07203352)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorNanfang Hospital, Southern Medical University

Started2025-10-01

View on ClinicalTrials.gov ↗

Nanfang Hospital, Southern Medical University

182 trials monitored

See 2 trials at risk

Leukemia

2,553 trials monitored

See 134 trials at risk

Acute Lymphoblastic Leukemia (ALL)

873 trials monitored

See 52 trials at risk

This prospective, randomized, controlled trial evaluates the efficacy and safety of a new targeted drug combined with chemotherapy versus standard chemotherapy alone. Eligible patients were randomized 1:1 to either the treatment or control group.

Trial Details

NCT Number	NCT07203352
Lead Sponsor	Nanfang Hospital, Southern Medical University
Conditions	Acute Lymphoblastic Leukemia
Enrollment	154 participants
Start Date	2025-10-01
Primary Completion	2026-12-01 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-10-02